MENU
SUPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Supernus Pharmaceuticals (SUPN) Earnings Date & Reports

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company... Show more

A.I. Advisor
published Earnings

SUPN is expected to report earnings to rise 38.26% to 37 cents per share on May 13

Supernus Pharmaceuticals SUPN Stock Earnings Reports
Q1'25
Est.
$0.37
Q4'24
Missed
by $0.06
Q3'24
Beat
by $0.25
Q2'24
Beat
by $0.37
Q1'24
Missed
by $0.38
The last earnings report on February 25 showed earnings per share of 27 cents, missing the estimate of 33 cents. With 1.32M shares outstanding, the current market capitalization sits at 1.84B.
View a ticker or compare two or three
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer for the treatment of central nervous system

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
9715 Key West Avenue
Phone
+1 301 838-2500
Employees
652
Web
https://www.supernus.com